Item

NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors

Gao, X.
Patnaik, A.
Lakhani, N. J.
Call, J. A.
Galsky, M. D.
Garmezy, B.
Wei, A. Z.
Carter, L.
Powles, T.
Siefker-Radtke, A. O.
... show 10 more
Keywords
Type
Meetings and Proceedings
Citation
Gao X, Patnaik A, Lakhani NJ, Call JA, Galsky MD, Garmezy B, et al. NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors. JOURNAL OF CLINICAL ONCOLOGY. 2025 FEB 10;43(5_SUPPL):TPS900-TPS. PubMed PMID: WOS:001454666200012. English.
Journal Title
Journal ISSN
Volume Title
Embedded videos